Home » Topics » Disease categories and therapies » Urology

Urology
RSS

RPR launches room-temperature formulation of DDAVP

July 16, 1997

Selective alpha1a-adrenoceptor blockers described by Merck & Co.

July 10, 1997

Natural products for the treatment of BPH

July 9, 1997

Agents for BPH claimed by Merck & Co.

July 8, 1997

Hemodialyzer efficacy established in patients

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Shire acquires distribution rights for Urispas from Recordati

July 2, 1997

Joint venture formed to market RenaGel

June 19, 1997

RPR seeks FDA approval for DDAVP tablets for bed-wetting

June 19, 1997

Compounds for urinary incontinence from Kyowa Hakko

June 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...